Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...

PRNewswireLondon [UK]/ Munich [Germany]/ New Delhi [India], February 4: Datar Cancer Genetics (DCG) has launched Exacta AI, a ...

Shares of Tempus AI , Inc. (NASDAQ:TEM) climbed 5% in pre-open trading Tuesday following the completion of its acquisition of ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.

The next leap in AI-driven healthcare requires brain power, a huge investment of money, and the courage to implement.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Advanced AI genetics models have been applied to Parkinson's disease, identifying genetic factors in its progression and potential FDA-approved drugs for repurposing.

In a retrospective study of 265 patients with drug-resistant solid organ cancers, ‘Exacta AI’ provided at least seven therapy ...

The Stargate Project plans to build data centers and energy infrastructure to harness next-generation AI and could ...

This collaboration will streamline the ordering and delivery of molecular tests, enabling healthcare providers to electronically order and track Prolaris and MyRisk tests, with results delivered ...